In addition, the tumorigenicity of cancer stem cells was found to be promoted by EZH2 via the binding and methylation of STAT3 in glioblastoma and in a model of prostate cancer (Xu et al., 2012; Kim et al., 2013). Here, EZH2 is linked to prostate cancer.